c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT. (Q38987143)

8 September 2017

title

c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT. (English)

1 reference

non-small-cell lung carcinoma

8 September 2017

1 reference

1 reference

D-W Wu

1

1 reference

8 September 2017

N-Y Hsu

2

1 reference

8 September 2017

Y-C Wang

3

1 reference

8 September 2017

M-C Lee

4

1 reference

8 September 2017

Y-W Cheng

5

1 reference

8 September 2017

C-Y Chen

6

1 reference

8 September 2017

H Lee

7

1 reference

8 September 2017

language of work or name

English

0 references

publication date

9 June 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

34

1 reference

8 September 2017

issue

16

1 reference

8 September 2017

page(s)

2072-2082

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2014.152

8 September 2017

exact match

0 references

cites work

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

DNA methyltransferases, DNA damage repair, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Widespread microRNA repression by Myc contributes to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Frequent p16INK4a promoter hypermethylation in human papillomavirus-infected female lung cancer in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

c-Myc and downstream targets in the pathogenesis and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Sensitive Melting Analysis after Real Time- Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.152

Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma

31 March 2020

1 reference

12 December 2020

Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients.

1 reference

12 December 2020

Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.

1 reference

12 December 2020

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas

1 reference

12 December 2020

Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma

1 reference

12 December 2020

Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease

1 reference

12 December 2020

Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2014.152

1 reference

Dimensions Publication ID

8 September 2017

1003942751

0 references

1 reference